(Bloomberg) — Canada’s University Health Network said its Toronto Western Hospital would be the first non-US site of a trial for a device created by Neuralink Corp., Elon Musk’s brain-implant company. 

Neuralink, founded by Elon Musk, receives approval for clinical trial in Canada to help paralyzed individuals control devices with thoughts.